Divestiture • Medical Products

Johnson & Johnson Acquires Abbott Medical Optics

On September 16, 2016, Johnson & Johnson acquired medical products company Abbott Medical Optics from Abbott for 4.3B USD

Acquisition Context
  • This is Johnson & Johnson’s 14th transaction in the Medical Products sector.
  • This is Johnson & Johnson’s 9th largest (disclosed) transaction.
  • This is Johnson & Johnson’s 27th transaction in the United States.
  • This is Johnson & Johnson’s 12th transaction in California.

Explore All 633 Divestiture Medical Products Deals - Search the Database Free


M&A Deal Summary

Date September 16, 2016
Target Abbott Medical Optics
Sector Medical Products
Buyer(s) Johnson & Johnson
Sellers(s) Abbott
Deal Type Divestiture
Deal Value 4.3B USD

Target Company

Abbott Medical Optics

Santa Ana, California, United States
Abbott Medical Optics, Inc. is a manufacturer of ophthalmic surgery products and is known for world-class intraocular lenses used in cataract surgery. The World Health Organization estimates that approximately 20 million people are blind from age-related cataracts and that there are at least 100 million eyes with compromised visual acuity caused by cataracts. These numbers are steadily rising due to population growth and increasing life expectancy.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Johnson & Johnson

New Brunswick, New Jersey, United States

Category Company
Founded 1886
Sector Consumer Products
Employees132,000
Revenue 88.8B USD (2024)
DESCRIPTION
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.
Johnson & Johnson's corporate headquarters in New Brunswick, New Jersey.

Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.


Deal Context for Buyer #
Overall 32 of 47
Sector: Medical Products 14 of 17
Type: Divestiture 4 of 4
State: California 12 of 15
Country: United States 27 of 39
Year: 2016 3 of 3
Size (of disclosed) 9 of 31
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-25 Johnson & Johnson - REMBRANDT

New Brunswick, New Jersey, United States

Johnson & Johnson - REMBRANDT is a developer of whitening toothpaste and later expanded its product offerings within the dental whitening category. The brand is synonymous with quality whitening products and provides Ranir an additional platform for the growing teeth whitening segment.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-26 Actelion

Allschwil, Switzerland

Actelion Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical need. Actelion is a leader in the field of pulmonary arterial hypertension (PAH). The Company's portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications. Although not available in all countries, Actelion has treatments approved by health authorities for a number of specialist diseases including Type 1 Gaucher disease, Niemann-Pick type C disease, Digital Ulcers in patients suffering from systemic sclerosis, and mycosis fungoides type cutaneous T-cell lymphoma. Actelion was formed in 1997 and has its corporate headquarters in Allschwil, Switzerland.

Buy $30.0B

Seller Profile 1

SELLER

Abbott

North Chicago, Illinois, United States

Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.


Deal Context for Seller #
Overall 6 of 8
Sector: Medical Products 4 of 5
Type: Divestiture 4 of 6
State: California 1 of 1
Country: United States 5 of 7
Year: 2016 1 of 2
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-28 St. Jude Medical

Saint Paul, Minnesota, United States

St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.

Buy $25.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-18 Abbott Laboratories - Vado Steerable Sheath

Abbott Park, Illinois, United States

Abbott Laboratories, Inc. - Vado Steerable Sheath is a provider of healthcare medical products in us.

Sell -